Regulator withdraws from UIC session to discuss cannabis adverse events by Steve Jones February 20, 2025February 20, 2025 Hopes of being able to counter allegations that medicinal cannabis is leading to increasing patient harm […]
PharmaCann extends olive branch to Cookies US in bid to end branding dispute ‘on a good note’ by Steve Jones February 20, 2025February 20, 2025
Medical bodies urged to provide evidence of ‘increasing harm’ after rounding on cannabis – again by Steve Jones February 20, 2025February 20, 2025
Changes on the horizon but exit of pharmaceutical market ‘not currently on the table’, says Althea CEO by Steve Jones February 20, 2025February 20, 2025
Oz Medicann bolsters clinic network with acquisition of Lullaby Health by Steve Jones February 19, 2025February 20, 2025
Former police officers report widespread benefits in medicinal cannabis study by Steve Jones February 19, 2025February 20, 2025
‘We can only make progress through research,’ says ANTG science chief as firm taps into ‘academic horsepower’ by Steve Jones February 18, 2025February 20, 2025
Althea slashes revenue guidance and sales forecast, scraps vape project by Steve Jones February 13, 2025February 13, 2025
Collapsed Releaf Group in liquidation but questions remain as anger erupts among creditors by Steve Jones February 13, 2025February 13, 2025
Fresh real-world data demonstrates success of cannabis in treating PTSD – but DVA remains unmoved by Steve Jones February 12, 2025February 12, 2025
